Roles and tissue source of adiponectin involved in lifestyle modifications

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 2, 2013, Pages 117-128

  Dai, Yang ^a,b   Pang, Jing ^b   Gong, Huan ^b   Fan, Wei ^a   Zhang, Tie Mei ^b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Adiponectin; Diabetes; Insulin sensitivity; Lifestyle modification

Indexed keywords

RATTUS;

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, RAT; ADIPOQ PROTEIN, RAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; SIRT1 PROTEIN, RAT; SIRTUIN 1;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; CALORIC RESTRICTION; CELL LINE; DRUG ANTAGONISM; EXERCISE; GENE SILENCING; GENETICS; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLISM; MYOBLAST; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALORIC RESTRICTION; CELL LINE; DIABETES MELLITUS, TYPE 2; GENE KNOCKDOWN TECHNIQUES; INSULIN RESISTANCE; LIFE STYLE; LIPIDS; MALE; MUSCLE, SKELETAL; MYOBLASTS; PHYSICAL EXERTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; SIRTUIN 1; TISSUE DISTRIBUTION;

EID: 84871734497     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls131     Document Type: Article

References (57)

1. Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799-806. (Pubitemid 34000783)
2. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature. 2006;444(7121):868-874. (Pubitemid 46024994)
3. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
4. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350. (Pubitemid 32378388)
5. Gilliland SS, Azen SP, Perez GE, Carter JS. Strong in body and spirit: lifestyle intervention for Native American adults with diabetes in New Mexico. Diabetes Care. 2002;25(1):78-83. (Pubitemid 41070787)
6. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783-1789. (Pubitemid 351697954)
7. Allard JS, Heilbronn LK, Smith C, et al. In vitro cellular adaptations of indicators of longevity in response to treatment with serum collected from humans on calorie restricted diets. PLoS One. 2005;3(9):e3211.
8. Manigrasso MR, Ferroni P, Santilli F, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab. 2005;90(10):5876-5879. (Pubitemid 41415505)
9. Polak J, Kovacova Z, Holst C, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur J Endocrinol. 2008;158(4):533-541. (Pubitemid 351606349)
10. Kondo M, Shibata R, Miura R, et al. Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase. J Biol Chem. 2009;284(3):1718-1724.
11. Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R. Cardio-protective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation. 2007;116(24):2809-2817. (Pubitemid 350291223)
12. Balagopal P, George D, Yarandi H, Funanage V, Bayne E. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab. 2005;90(11):6192-6197. (Pubitemid 41606543)
13. Giannopoulou I, Fernhall B, Carhart R, et al. Effects of diet and/or exercise on the adipocytokine and infl ammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism. 2005;54(7):866-875. (Pubitemid 40827201)
14. Blüher M, Bullen JW Jr, Lee JH, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab. 2006;91(6):2310-2316. (Pubitemid 43855022)
15. Mather KJ, Funahashi T, Matsuzawa Y, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes. 2008;57(4):980-986.
16. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adipo-nectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-1792. (Pubitemid 44033298)
17. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003;88(10):4823-4831. (Pubitemid 37357532)
18. Moore AF, Jablonski KA, McAteer JB, et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes. 2008;57(9):2503-2510.
19. Cambuli VM, Musiu MC, Incani M, et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab. 2008;93(8):3051- 3057.
20. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288-1295. (Pubitemid 35373562)
21. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adipo-nectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941-946. (Pubitemid 32756432)
22. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884-1888. (Pubitemid 34564302)
23. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390-392. (Pubitemid 38938153)
24. Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458(7241):1056-1060.
25. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292-295. (Pubitemid 26033933)
26. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95(5):2409-2415.
27. de Cabo R, Fürer-Galbán S, Anson RM, Gilman C, Gorospe M, Lane MA. An in vitro model of caloric restriction. Exp Gerontol. 2003; 38(6):631-639. (Pubitemid 36694165)
28. Gupte AA, Bomhoff GL, Swerdlow RH, Geiger PC. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes. 2009;58(3):567-578.
29. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specifi c gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697-10703. (Pubitemid 26145805)
30. Pang J, Gong H, Xi C, Fan W, Dai Y, Zhang TM. Poly (ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes. J Cell Biochem. 2011;112(1):299-306.
31. Gong H, Zhang TM. Prepare of a rat model with different insulin sensitivity by different diet composition and feeding patterns. Chin J Diabetes. 2005;13(6):456-462.
32. Cantó C, Auwerx J. Calorie restriction: is AMPK a key sensor and effector? Physiology (Bethesda). 2011;26(4):214-224.
33. Civitarese AE, Carling S, Heilbronn LK, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007;(3):4e76.
34. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746-26749.
35. Wang Y, Lam KS, Chan L, et al. Post-translational modifi cations of the four conserved lysine residues within the collagenous domain of adi-ponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem. 2006;281(24):16391-16400.
36. Kraemer RR, Aboudehen KS, Carruth AK, Durand RT, Acevedo EO. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc. 2003;35(8):1320-1325. (Pubitemid 36936150)
37. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care. 2004;27(2):629-630. (Pubitemid 38174107)
38. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specifi c protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595-1599. (Pubitemid 30353893)
39. Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specifi c secretory protein adiponectin. Diabetes. 2003;52(2):268-276. (Pubitemid 36173178)
40. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by infl ammatory cytokines: in vivo and in vitro studies. Endocrinology. 2004;145(12):5589-5597. (Pubitemid 39564599)
41. Ding G, Fu M, Qin Q, et al. Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxida-tive damage. Cardiovasc Res. 2007;76(2):269-279. (Pubitemid 350198591)
42. Liu Y, Chewchuk S, Lavigne C, et al. Functional signifi cance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. Am J Physiol Endocrinol Metab. 2009;297(3):E657-E664.
43. Yang B, Chen L, Qian Y, et al. Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochem Biophys Res Commun. 2006;341(1):209-217. (Pubitemid 43117406)
44. Krause MP, Liu Y, Vu V, et al. Adiponectin is expressed by skeletal muscle fi bers and infl uences muscle phenotype and function. Am J Physiol Cell Physiol. 2008;295(1):C203-C212. (Pubitemid 352755800)
45. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379-1406.
46. Hyun DH, Emerson SS, Jo DG, Mattson MP, de Cabo R. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci U S A. 2006;103(52):19908- 19912. (Pubitemid 46037529)
47. Li L, Pan R, Li R, et al. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacety-lation by physical activity: intact adipocytokine signaling is required. Diabetes. 2011;60(1):157-167.
48. Larson-Meyer DE, Newcomer BR, Heilbronn LK, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring). 2008;16(6):1355-1362. (Pubitemid 351770499)
49. Crossno JT Jr, Majka SM, Grazia T, Gill RG, Klemm DJ. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest. 2006;116(12):3220-3228. (Pubitemid 44878636)
50. (2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313-1319.
51. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardiopro-tection in mice. J Clin Invest. 2010;120(12):4342-4352.
52. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762-769. (Pubitemid 36735700)
53. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004;101(28):10308-10313. (Pubitemid 38924921)
54. Pold R, Jensen LS, Jessen N, et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes. 2005;54(4):928-934. (Pubitemid 40446305)
55. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1):258S-261S.
56. Rasouli N, Yao-Borengasser A, Miles LM. Increased plasma adipo-nectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab. 2006;290(1):E42-E46.
57. Hipkiss AR. Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms? Biogerontology. 2008;9(1):49-55.